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an

IN-DEPTH LOOK
at STALL
CONTAMINATION
A TOTAL OF 28 SUBSTANCES WERE IDENTIFIED
IN CHARLES TOWN SHIP-IN STALLS AS
A MIX OF HUMAN MEDICATIONS AND
RECREATIONAL SUBSTANCES WITH
SOME ACTUAL EQUINE MEDICATIONS

Denis Blake

By Clara Fenger, DVM, PhD, DACVIM, Maria Catignani,
Jake Machin and Thomas Tobin, MRCVS, PhD, DABT

This story is important because it involves, to our
knowledge, the first-ever broad-based high-sensitivity
testing of ship-in stalls at a North American racetrack. The
story begins in August 2015, when Charles Town Races
changed its drug-testing contract to the highly capable
Denver-based Industrial Laboratories and also adopted the
Racing Medication and Testing Consortium (RMTC) controlled
therapeutic medication schedule.
One unanticipated outcome of these changes was the
appearance of a sporadic sequence of low-concentration
naproxen positives, mostly among trainers shipping in from
Mid-Atlantic states to race at Charles Town. As of January 1,
2017, these identifications were all in plasma and ran from
a miniscule 6.3 ng/ml to 161 ng/ml. Although these plasma
concentrations of naproxen are readily detectable by modern,
high-sensitivity testing methods, these concentrations are
not pharmacologically significant, especially given that the
neighboring Mid-Atlantic states were regulating naproxen at
a 1,000 ng/ml plasma threshold.
Naproxen is the poster child for stall contamination.
The naproxen dose is large—5 grams/horse twice a day,
given orally. The stall becomes contaminated beginning with
WWW.HBPA.ORG

41

FEATURE

the naproxen that inadvertently drips there with the first oral dose and soon
thereafter with the naproxen-laden urine that the horse spills into the stall.
The naproxen molecule is chemically stable, so it persists and will accumulate
in the stall. One way to tell if a stall is contaminated is to put a “clean” horse
into the stall and test the horse in a couple of days; if the stall is significantly
contaminated, the horse will test positive for naproxen.
Where were the naproxen positives in the Charles Town ship-ins coming
from? One possibility suggested by horsemen was that the ship-in stalls
themselves were naproxen-contaminated, providing a ready source of the
naproxen positives. Responding to this suggestion, West Virginia Racing
Commission personnel swabbed the ship-in stalls and sent the samples

As shown in Figure 1, cocaine and its
metabolites benzoylecgonine (BZE) and
ecgonine methyl ester were, not surprisingly,
the most frequently identified substances,
identified in 10 of the ship-in stalls tested.
This finding is fully consistent with the
widespread human recreational use of cocaine
and its well-established presence as a tracelevel environmental substance in human
environments. Traces of cocaine can be found
on 92 percent of circulating U.S. dollars. As a
result of the ubiquitous presence of cocaine in
the human environment, the Federal Aviation
Administration, Nuclear Regulatory Commission
and the U.S. Department of Transportation have
adopted a screening level of 150 ng/ml of its
BZE metabolite in human urine as not unusual
and indicative of nothing more than inadvertent
exposure of the human to trace-level amounts
of environmental cocaine. Similarly, some
horse racing jurisdictions have adopted a BZE
screening limit, ranging from 50 ng/ml to 150
ng/ml in a post-race urine sample.
Methamphetamine is also a widely used
human recreational substance, and there were
two amphetamine and one methamphetamine
identifications, fully consistent with the
increasingly common detection of trace levels
of methamphetamine in racing. One other
identification most likely related to human
recreational substance use was an identification
of methylenedioxypyrovalerone (MDPV) or
“bath salts” and an unexpected identification
of n-ethylnicotinamide, a metabolite of the
stimulant nikethamide. All in all, it is clear
confirmation of the widespread presence in the
racing environment, in this case in ship-in stalls,
of traces of human recreational substances.
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to Industrial Laboratories for analysis, leading to some, shall we say, very
interesting findings.
Presented below are data from the reports from Industrial Laboratories to
the West Virginia Racing Commission obtained under a public records request
by the Charles Town HBPA. We do not know precisely how the stalls were
swabbed/sampled; nevertheless, the results are very interesting indeed. And,
by way of background, the total number of ship-in stalls tested was 21, and
of that number, only four were negative for detected medications/substances,
starting with human recreational substances, as presented in Figure 1. One
additional stall had straw tested, and the straw was negative.

FIGURE 1: HUMAN RECREATIONAL SUBSTANCES FOUND
IN THE SHIP-IN STALLS AT CHARLES TOWN RACES

ALL IN ALL, IT IS CLEAR CONFIRMATION OF
THE WIDESPREAD PRESENCE IN THE RACING
ENVIRONMENT, IN THIS CASE IN SHIP-IN
STALLS, OF TRACES OF HUMAN
RECREATIONAL SUBSTANCES.

A total of 14 human prescription or over-the-counter
medication identifications were found in these 21 stalls,
shown in Figure 2. There were three identifications of
metoprolol, a human blood pressure medication; two each
of tramadol, a human opioid-type pain medication; and
methadone, an opioid used to treat pain and also as a
maintenance therapy for humans with opioid dependence.
One stall tested positive for oxycodone, an opioid widely
misused by humans in the current opioid epidemic in the
United States, for a total of five opiate identifications.
There were two identifications of metformin, a widely
used human type 2 diabetes medication, and two
identifications of meprobamate, a long-used human antianxiety medication, as well as a metabolite of carisoprodol
(Soma), a commonly prescribed human muscle relaxant
that is also occasionally used in horses.
Not entirely unexpectedly, there was one identification
listed as levorphanol/dextrorphan, presumably a passedthrough metabolite of dextromethorphan, the active
substance in a number of over-the-counter medications
such as NyQuil, as evidenced in a number of recent
dextrorphan identifications in Kentucky associated with
the use of NyQuil by the groom of at least one of the
involved horses. Finally, there was an identification of
ritalinic acid, presumably associated with urination
in the ship-in stall of an individual medicated with
methylphenidate/Ritalin. These ship-in stall findings of
tramadol, oxycodone and dextrorphan come as no surprise
to the racing community, with these substances being
identified as human prescription and over-the-counter
medications long suspected of transferring from humans
to racehorses and giving rise to trace-level urinary
identifications of these substances.
Finally, the equine substances (Figure 3) present in
the ship-in stalls totaled 21 individual identifications. The
status of naproxen was reported as “high-concentration”
in four stalls but was apparently detected at a low level in
almost all of the tested stalls, consistent with its posterchild status as an environmental substance. Three stalls
each tested positive for acepromazine and glycopyrrolate,
which is somewhat surprising for these relatively low-dose
medications. Two stalls each tested positive for ketoprofen
and flunixin. The flunixin findings were consistent with
its long-established role as a stall contaminant, even
when administered as an IV medication. There was
also one stall identification each of firocoxib, a highdose non-steroidal anti-inflammatory; guaifenesin;
isoxsuprine, another poster child for stall contamination;
a somewhat unexpected lidocaine; a fully to be expected
methocarbamol; and two not unexpected equine/human
anti-ulcer medications, omeprazole and ranitidine.

FIGURE 2: HUMAN THERAPEUTIC SUBSTANCES FOUND IN THE
SHIP-IN STALLS AT CHARLES TOWN RACES

FIGURE 3: EQUINE THERAPEUTIC SUBSTANCES FOUND IN THE
SHIP-IN STALLS AT CHARLES TOWN RACES
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THE CASE FOR ENVIRONMENTAL EXPOSURE GROWS
This space in The Horsemen’s Journal has been repeatedly filled with
examples of positive tests resulting from inadvertent environmental exposure
that have been implicated from sources as widely varied as contamination
from a groom’s hands of common cold remedies to the horse’s own urine. We
have discussed possible transfer from human urine, traces of medication on
hay nets, commingling of human prescriptions with tongue ties in pockets
or even transferred from the hands of an assistant starter onto the horse’s
mucous membranes. While some of these sources could be readily limited
by strict control by the trainer, others are completely outside the control of
horsemen. Nonetheless, the absolute insurer rule counts these meaningless
positive tests as equal to intentional administration of performance-enhancing
drugs. Some regulators, such as the Kentucky Horse Racing Commission, in the
case of dextrorphan, have come to the logical conclusion that some such tracepositive findings are irrelevant, whereas others continue to adhere to their
outdated zero-tolerance regulations.

THE EVIDENCE
Drugs in the environment are an emerging problem, not just for horse
racing, and it has entered the radar screen of our national regulatory bodies.
The Environmental Protection Agency commissioned a study evaluating the
effluents of 50 large wastewater treatment plants and found measurable levels
of 56 different pharmaceuticals, with a diuretic, hydrochlorothiazide, being
found in every sample analyzed. Among the drugs found were hypertensive
medications, metoprolol, atenolol, enalapril and narcotics, including
hydrocodone and oxycodone. Some of these drugs result from the flushing of
prescription drugs down the toilet, but most are actually from the urine of
humans taking the drugs. The levels of these environmental contaminants
in wastewater are mostly very low, unlikely to cause positive tests in
racing horses, but it underscores the significance of contamination in the
environment. Environmental contamination happens, with many of these drugs
stable enough in the environment to remain in the water even after wastewater
treatment.
More common sources of inadvertent environmental exposure for horses
are the horses themselves, the grooms in constant contact with the horses
under their care and others like racing officials. There has been credible
evidence of contamination of horses by casual contact with grooms, paddock
judges and assistant starters, and even contamination of blood or urine
samples during or after collection in the test barn. All of these positive tests
have been at very low, trace levels of identification, usually in urine, and at
levels well below those that may affect the physiology of the animal.
The problem of inadvertent environmental exposure was first outlined in a
group of scientific papers published in 2000 at the International Conference for
Racing Analysts and Veterinarians. In those proceedings, naproxen, ibuprofen,
isoxsuprine and flunixin were all shown to have positive tests consistent with
violations after exposure to very low concentrations of these drugs. In 2006
chlorpheniramine, dipyrone and meclofenamic acid were added to the list of
drugs for which such positives could be demonstrated. Recommended limits of
detection were suggested for therapeutic medications to avoid these irrelevant
positives from inadvertent environmental exposure.
The phenomenon of inadvertent environmental exposure to horses by their
own urine was clearly demonstrated in 2011 in a study by Dr. Marie-Agnès
Popot and others in France. They administered flunixin orally and intravenously
and bedded the horses on straw. The horses were grouped as follows:
1) those in deep stall bedding that was completely stripped and swept out
daily,
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2) those in thin stall bedding that was completely stripped and swept
out daily, and
3) those in deep stall bedding cleaned in the usual fashion with most of
the straw saved and the dirty removed.
At 24 hours after the drug was given, a horse was moved to a clean
stall in which no horse had been given flunixin. The findings were simple: All
groups, except the horse that was moved to a clean stall, experienced positive
tests associated with recycling of flunixin from the stall. The highest risk of a
positive test from this stall contamination was in the group with thin bedding
completely stripped daily.

DRUGS IN THE ENVIRONMENT
In 2008 Dr. Steven Barker performed a survey of the test barn and
receiving barn stalls at a racetrack in Louisiana. He sampled the dirt floors,
consciously avoiding regions of high suspicion, such as obvious areas of urine
and fecal contamination, collecting about 1 ½ ounces of dirt to screen for
drugs. He looked for common equine therapeutic medications, caffeine and
cotinine, a metabolite of nicotine. Phenylbutazone, flunixin, naproxen, caffeine
and furosemide were all readily identified in those stall samples, and all of the
samples collected contained cotinine. While none of those drugs were present
in sufficient concentrations to actually trigger a positive test, this study shows
that, even in what are expected to be the cleanest areas on the backside—the
test and receiving barns, where horses are generally not actually treated with
drugs routinely—the environment is contaminated with medications.
In the last edition of The Horsemen’s Journal, we outlined an investigation of
a cluster of naproxen positives at Charles Town. As stated earlier, the stalls in the
receiving barn were swabbed and tested for drugs in the environment as part of
the investigation by the West Virginia Racing Commission into this incident.
Several points can be surmised from the results. First, many of
the substances found in the stalls at Charles Town are found in trace
concentrations in post-race samples, often with the trainer and owner left
wondering where they came from. Second, these were the substances found in
the ship-in barn, and some substances, such as equine therapeutics, would be
expected to be much higher in the horses’ home stalls. Third, it is critical that
these studies be repeated at racetracks across the country; the absolute insurer
rule cannot hold a trainer responsible for substances inadvertently picked up
by a horse in a receiving barn, test barn or other area not under their direct
control. Finally, these issues can readily be addressed using recommended
screening limits, like the limits of detection originally recommended by Duluard
and others in 2006, for substances of inadvertent environmental exposure.

RCI MODEL RULES
ARCI-025-020§H2 recognizes that “substances of human use and
addiction and which could be found in the horse due to its close association
with humans” should be identified, but as yet, there are no screening limits
established for such substances in the model rules.
The National HBPA and North American Association of Racetrack
Veterinarians have joined together to propose screening limits for three of the
substances of concern, two of which are prominently featured in the Charles
Town investigation: methamphetamine and cocaine and its metabolites. We
urge jurisdictions to consider our proposal in light of the evidence outlined
in this article and join us in moving horse racing past the penalizing of our
horsemen and owners because of highly sensitive testing equipment.

